Clinical findings of methicillin-resistant Staphylococcus aureus in cystic fibrosis

Background. Methicillin-resistant Staphylococcus aureus (MRSA) rates have increased in cystic fibrosis (CF) patients.This study aimed to determine the rate of MRSA, define risk factors, and clarify the effect of MRSA on pulmonary functions, annual pulmonary exacerbation (aPEx) in children wit...

Full description

Saved in:
Bibliographic Details
Main Authors: Beste Özsezen, Uğur Özçelik, Ebru Yalçın, Gülşen Hazırolan, İsmail Güzelkaş, Halime Nayır Büyükşahin, Birce Sunman, Dilber Ademhan Tural, Nagehan Emiralioğlu, Deniz Doğru, Nural Kiper
Format: Article
Language:English
Published: Hacettepe University Institute of Child Health 2022-10-01
Series:The Turkish Journal of Pediatrics
Subjects:
Online Access:https://turkjpediatr.org/article/view/217
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850042979701489664
author Beste Özsezen
Uğur Özçelik
Ebru Yalçın
Gülşen Hazırolan
İsmail Güzelkaş
Halime Nayır Büyükşahin
Birce Sunman
Dilber Ademhan Tural
Nagehan Emiralioğlu
Deniz Doğru
Nural Kiper
author_facet Beste Özsezen
Uğur Özçelik
Ebru Yalçın
Gülşen Hazırolan
İsmail Güzelkaş
Halime Nayır Büyükşahin
Birce Sunman
Dilber Ademhan Tural
Nagehan Emiralioğlu
Deniz Doğru
Nural Kiper
author_sort Beste Özsezen
collection DOAJ
description Background. Methicillin-resistant Staphylococcus aureus (MRSA) rates have increased in cystic fibrosis (CF) patients.This study aimed to determine the rate of MRSA, define risk factors, and clarify the effect of MRSA on pulmonary functions, annual pulmonary exacerbation (aPEx) in children with MRSA positive CF. Methods. This was a retrospective case control study. CF patients who had ≥1 MRSA (+) respiratory culture between September 2016-2019 were included. MRSA growth rate, colonization status, clinical characteristics, hospitalization rates, FEV1 %predicted, and z-score one year prior to the MRSA isolation, at MRSA growth and one year after MRSA growth were recorded. The aPEx rate changes before-after MRSA growth were evaluated. Results. Sixty-one subjects who had ≥1MRSA growth and 66 controls were enrolled. There was no statistically significant difference between the spirometry indices at first, and 12th month after MRSA acquisition. The mean aPEx was 0.6 one year prior to MRSA acquisition and this rate significantly increased to 1.2 one year after MRSA growth(p < 0.05). The mean hospitalization rate before and after one year of MRSA acquisition significantly increased from 0.17(±0.12) to 0.48 (±0.3)(p:0.008) admissions per year. Conclusions. MRSA growth was related to increased aPEx. Increased aPEx and hospitalization rates after MRSA acquisition suggest MRSA should be eradicated when detected.
format Article
id doaj-art-b82ba275524241ef91a0691c7e71089b
institution DOAJ
issn 0041-4301
2791-6421
language English
publishDate 2022-10-01
publisher Hacettepe University Institute of Child Health
record_format Article
series The Turkish Journal of Pediatrics
spelling doaj-art-b82ba275524241ef91a0691c7e71089b2025-08-20T02:55:21ZengHacettepe University Institute of Child HealthThe Turkish Journal of Pediatrics0041-43012791-64212022-10-0164510.24953/turkjped.2021.5050Clinical findings of methicillin-resistant Staphylococcus aureus in cystic fibrosisBeste Özsezen0Uğur Özçelik1Ebru Yalçın2Gülşen Hazırolan3İsmail Güzelkaş4Halime Nayır Büyükşahin5Birce Sunman6Dilber Ademhan Tural7Nagehan Emiralioğlu8Deniz Doğru9Nural Kiper10Departments of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.Departments of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.Departments of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.Departments of Medical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.Departments of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.Departments of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.Departments of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.Departments of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.Departments of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.Departments of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.Departments of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Türkiye. Background. Methicillin-resistant Staphylococcus aureus (MRSA) rates have increased in cystic fibrosis (CF) patients.This study aimed to determine the rate of MRSA, define risk factors, and clarify the effect of MRSA on pulmonary functions, annual pulmonary exacerbation (aPEx) in children with MRSA positive CF. Methods. This was a retrospective case control study. CF patients who had ≥1 MRSA (+) respiratory culture between September 2016-2019 were included. MRSA growth rate, colonization status, clinical characteristics, hospitalization rates, FEV1 %predicted, and z-score one year prior to the MRSA isolation, at MRSA growth and one year after MRSA growth were recorded. The aPEx rate changes before-after MRSA growth were evaluated. Results. Sixty-one subjects who had ≥1MRSA growth and 66 controls were enrolled. There was no statistically significant difference between the spirometry indices at first, and 12th month after MRSA acquisition. The mean aPEx was 0.6 one year prior to MRSA acquisition and this rate significantly increased to 1.2 one year after MRSA growth(p < 0.05). The mean hospitalization rate before and after one year of MRSA acquisition significantly increased from 0.17(±0.12) to 0.48 (±0.3)(p:0.008) admissions per year. Conclusions. MRSA growth was related to increased aPEx. Increased aPEx and hospitalization rates after MRSA acquisition suggest MRSA should be eradicated when detected. https://turkjpediatr.org/article/view/217colonizationcystic fibrosismethicillin resistant Staphylococcus aureuspulmonary exacerbationtreatment
spellingShingle Beste Özsezen
Uğur Özçelik
Ebru Yalçın
Gülşen Hazırolan
İsmail Güzelkaş
Halime Nayır Büyükşahin
Birce Sunman
Dilber Ademhan Tural
Nagehan Emiralioğlu
Deniz Doğru
Nural Kiper
Clinical findings of methicillin-resistant Staphylococcus aureus in cystic fibrosis
The Turkish Journal of Pediatrics
colonization
cystic fibrosis
methicillin resistant Staphylococcus aureus
pulmonary exacerbation
treatment
title Clinical findings of methicillin-resistant Staphylococcus aureus in cystic fibrosis
title_full Clinical findings of methicillin-resistant Staphylococcus aureus in cystic fibrosis
title_fullStr Clinical findings of methicillin-resistant Staphylococcus aureus in cystic fibrosis
title_full_unstemmed Clinical findings of methicillin-resistant Staphylococcus aureus in cystic fibrosis
title_short Clinical findings of methicillin-resistant Staphylococcus aureus in cystic fibrosis
title_sort clinical findings of methicillin resistant staphylococcus aureus in cystic fibrosis
topic colonization
cystic fibrosis
methicillin resistant Staphylococcus aureus
pulmonary exacerbation
treatment
url https://turkjpediatr.org/article/view/217
work_keys_str_mv AT besteozsezen clinicalfindingsofmethicillinresistantstaphylococcusaureusincysticfibrosis
AT ugurozcelik clinicalfindingsofmethicillinresistantstaphylococcusaureusincysticfibrosis
AT ebruyalcın clinicalfindingsofmethicillinresistantstaphylococcusaureusincysticfibrosis
AT gulsenhazırolan clinicalfindingsofmethicillinresistantstaphylococcusaureusincysticfibrosis
AT ismailguzelkas clinicalfindingsofmethicillinresistantstaphylococcusaureusincysticfibrosis
AT halimenayırbuyuksahin clinicalfindingsofmethicillinresistantstaphylococcusaureusincysticfibrosis
AT bircesunman clinicalfindingsofmethicillinresistantstaphylococcusaureusincysticfibrosis
AT dilberademhantural clinicalfindingsofmethicillinresistantstaphylococcusaureusincysticfibrosis
AT nagehanemiralioglu clinicalfindingsofmethicillinresistantstaphylococcusaureusincysticfibrosis
AT denizdogru clinicalfindingsofmethicillinresistantstaphylococcusaureusincysticfibrosis
AT nuralkiper clinicalfindingsofmethicillinresistantstaphylococcusaureusincysticfibrosis